MARC Record from marc_columbia

LEADER: 05982cam a2200769 i 4500
001 15130172
005 20220219230814.0
006 m o d
007 cr cnu---unuuu
008 180201s2018 flu ob 001 0 eng d
035 $a(OCoLC)on1021174054
035 $a(NNC)15130172
040 $aN$T$beng$erda$epn$cN$T$dOCLCO$dYDX$dCRCPR$dN$T$dNLE$dOCLCO$dOCLCF$dD6H$dNRC$dOCLCQ$dOCLCO$dERL$dMERER$dOCLCO$dOCLCQ$dU3W$dOCLCO$dOCLCQ$dOCLCO$dCAUOI$dUKMGB$dCOO$dWYU$dOCLCA$dOCLCQ$dOCLCA$dVT2$dTYFRS$dOCLCQ$dUKAHL$dOL$$dOCLCO$dEBLCP$dESU$dMM9$dOCLCQ
015 $aGBB833478$2bnb
016 7 $a018727400$2Uk
019 $a1019662724$a1022601630$a1066593171$a1077412354$a1084378822$a1171309784
020 $a9781315313153$q(electronic bk.)
020 $a1315313154$q(electronic bk.)
020 $a9781315313177
020 $a1315313170
020 $a9781315313160
020 $a1315313162
020 $a9781315313146
020 $a1315313146
020 $z9781138033283
020 $z1138033286
035 $a(OCoLC)1021174054$z(OCoLC)1019662724$z(OCoLC)1022601630$z(OCoLC)1066593171$z(OCoLC)1077412354$z(OCoLC)1084378822$z(OCoLC)1171309784
037 $a9781315313153$bIngram Content Group
050 4 $aRA1228
060 4 $aQV 55
072 7 $aMED$x030000$2bisacsh
072 7 $aMED$x076000$2bisacsh
072 7 $aMED$x078000$2bisacsh
082 04 $a614/.13$223
049 $aZCUA
245 00 $aChromatographic techniques in the forensic analysis of designer drugs /$ceditors, Teresa Kowalska, Mieczyslaw Sajewicz, Joseph Sherma.
264 1 $aBoca Raton :$bTaylor & Francis/CRC Press,$c[2018]
300 $a1 online resource
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
490 1 $aChromatographic science series
504 $aIncludes bibliographical references and index.
505 0 $aDesigner drugs : legislating for tomorrow through the use of class definitions and pharmacophore principles / Gregory W. Endres, Travis J. Worst, Jon E. Sprague -- Alternative legislation with designer drugs / Dariusz Zuba -- Biological precursors of designer drugs / Lukasz Komsta, Katarzyna Wicha-Komsta -- Liquid chromatography : mass spectrometry in analysis of designer drugs / Beril Anilanmert -- Ambient plasma ionization techniques in forensic analysis / Przemyslaw Mielczarek, Marek Smoluch -- Application of LC-QTOFMS for the identification of the structure of new psychoactive substances / Karolina Sekula, Dariusz Zuba -- Rapid generation of metabolites by electrochemical method / Przemyslaw Mielczarek, Marek Smoluch -- Gas chromatography : mass spectrometry in analysis of designer drugs / Bogumila Byrska, Roman Stanaszek -- NMR spectroscopy in the analysis of illegal drugs / Vlatka Vajs, Iris Djordjevic, Ljubodrag Vujisic, Slobodan M. Milosavljevic -- Preparation of biological material for toxicological analysis / Milena Majchrzak, Rafal Celinski -- Discrimination among the designer drug isomers by chromatographic and spectrometric methods / Piotr Adamowicz, Dariusz Zuba -- Mass spectrometric analysis applied for deteramination of synthetic cannabinoids / Akira Namera, Takeshi Saito, Yuji Fujita -- Cathinone derivatives and their analysis / Milena Majchrzak, Rafal Celinski -- 2C derivatives of phenylethylamines and their analysis / Beril Anilanmert, Fatma Çavus, Ali Acar Ozdemir -- NBOMe derivatives of phenylethylamines and their analysis / Beril Anilanmert, Fatma Çavus, Sena Caglar Andac -- The forensic analysis of piperazines / Michael D. Cole, Chipo Kuleya -- Fenantyl analogues and their analysis / Thomas A. Brettell, Matthew R. Wood -- Modern techniques for the identification of tryptamines / Dariusz Zuba -- Toxicological analysis of new opioids / Artur Tezyk, Karina Sommerfeld, Bogna Geppert -- Toxicological analysis of designer benzodiazepines / Artur Tezyk, Karina Sommerfeld, Bogna Geppert -- Thin-layer chromatography in the analysis of designer drugs / Joseph Sherma, Teresa Kowalska, Mieczyslaw Sajewicz.
588 0 $aPrint version record.
520 2 $a"There is a dramatic rise of novel drug use due to the increased popularity of so-called designer drugs. These synthetic drugs can be illegal in some countries, but legal in others and novel compounds unknown to drug chemistry emerge monthly. This thoughtfully constructed edited reference presents the main chromatographic methodologies and strategies used to discover and analyze novel designer drugs contained in diverse biological materials. The methods are based on molecular characteristics of the drugs belonging to each individual class of compounds, so it will be clear how the current methods are adaptable to future new drugs that appear in the market."--Provided by publisher
650 0 $aDesigner drugs$xAnalysis.
650 0 $aChromatographic analysis.
650 0 $aForensic toxicology.
650 12 $aDesigner Drugs$xanalysis.
650 22 $aForensic Toxicology.
650 22 $aChromatography$xmethods.
650 22 $aMass Spectrometry$xmethods.
650 7 $aMEDICAL$xForensic Medicine.$2bisacsh
650 7 $aMEDICAL$xPreventive Medicine.$2bisacsh
650 7 $aMEDICAL$xPublic Health.$2bisacsh
650 7 $aChromatographic analysis.$2fast$0(OCoLC)fst00859925
650 7 $aDesigner drugs$xAnalysis.$2fast$0(OCoLC)fst00891340
650 7 $aForensic toxicology.$2fast$0(OCoLC)fst00932027
655 4 $aElectronic books.
700 1 $aKowalska, Teresa,$eeditor.
700 1 $aSajewicz, Mieczyslaw,$eeditor.
700 1 $aSherma, Joseph,$eeditor.
776 08 $iPrint version:$tChromatographic techniques in the forensic analysis of designer drugs.$dBoca Raton : Taylor & Francis/CRC Press, 2018$z9781138033283$w(DLC) 2017041428$w(OCoLC)1007507991
830 0 $aChromatographic science.$x0069-3936
856 40 $uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio15130172$zTaylor & Francis eBooks
852 8 $blweb$hEBOOKS